- Home
- HAFC vs IMTX Comparison
HAFC vs IMTX Comparison
Compare HAFC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAFC
- IMTX
- Stock Information
- Founded
- HAFC 1982
- IMTX N/A
- Country
- HAFC United States
- IMTX Germany
- Employees
- HAFC N/A
- IMTX N/A
- Industry
- HAFC Major Banks
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HAFC Finance
- IMTX Health Care
- Exchange
- HAFC Nasdaq
- IMTX Nasdaq
- Market Cap
- HAFC 650.5M
- IMTX 579.8M
- IPO Year
- HAFC 1996
- IMTX N/A
- Fundamental
- Price
- HAFC $23.87
- IMTX $4.46
- Analyst Decision
- HAFC Buy
- IMTX Strong Buy
- Analyst Count
- HAFC 6
- IMTX 4
- Target Price
- HAFC $25.75
- IMTX $16.67
- AVG Volume (30 Days)
- HAFC 159.6K
- IMTX 439.7K
- Earning Date
- HAFC 04-22-2025
- IMTX 05-13-2025
- Dividend Yield
- HAFC 4.48%
- IMTX N/A
- EPS Growth
- HAFC N/A
- IMTX N/A
- EPS
- HAFC 2.13
- IMTX N/A
- Revenue
- HAFC $231,876,000.00
- IMTX $155,801,989.00
- Revenue This Year
- HAFC $18.47
- IMTX N/A
- Revenue Next Year
- HAFC $7.43
- IMTX $4.92
- P/E Ratio
- HAFC $11.32
- IMTX N/A
- Revenue Growth
- HAFC N/A
- IMTX 188.60
- 52 Week Low
- HAFC $14.95
- IMTX $3.30
- 52 Week High
- HAFC $27.59
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- HAFC 61.60
- IMTX 48.56
- Support Level
- HAFC $22.22
- IMTX $4.15
- Resistance Level
- HAFC $24.50
- IMTX $4.83
- Average True Range (ATR)
- HAFC 0.71
- IMTX 0.37
- MACD
- HAFC 0.12
- IMTX -0.04
- Stochastic Oscillator
- HAFC 74.78
- IMTX 35.37
About HAFC Hanmi Financial Corporation
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. Hanmi also offers trade-finance products. The bank has several lending offices outside California and plans to expand outside the state mainly through acquisitions. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.